Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11106
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Patel, Oneel | en |
dc.contributor.author | Marshall, Kathryn M | en |
dc.contributor.author | Bramante, Gianni | en |
dc.contributor.author | Baldwin, Graham S | en |
dc.contributor.author | Shulkes, Arthur | en |
dc.date.accessioned | 2015-05-16T00:41:37Z | |
dc.date.available | 2015-05-16T00:41:37Z | |
dc.date.issued | 2010-08-19 | en |
dc.identifier.citation | Regulatory Peptides 2010; 165(2-3): 224-31 | en |
dc.identifier.govdoc | 20727916 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/11106 | en |
dc.description.abstract | Progastrin is processed to a number of peptides including glycine-extended gastrin, amidated gastrin and the C-terminal flanking peptide (CTFP). Progastrin and gastrin-gly are pro-proliferative and anti-apoptotic in gastric and colorectal cancer cell lines. The CTFP is a major form of progastrin in the stomach and colon and stimulates proliferation. However the effect of CTFP on apoptosis has not been examined. Using the human gastric carcinoma cell line AGS we show that CTFP attenuates apoptosis through a PI3-kinase pathway by stimulating the phosphorylation of Akt leading to sustained increases in the concentrations of Bcl-xL and phosphorylated Bad protein and by reducing caspase 3 activity. The anti-apoptotic effect represents an important potential mechanism for the growth promoting action of CTFP. | en |
dc.language.iso | en | en |
dc.subject.other | Apoptosis.drug effects | en |
dc.subject.other | Blotting, Western | en |
dc.subject.other | Cell Line, Tumor | en |
dc.subject.other | Cell Survival.drug effects | en |
dc.subject.other | Flow Cytometry | en |
dc.subject.other | Gastrins.chemistry | en |
dc.subject.other | Humans | en |
dc.subject.other | Peptide Fragments.chemistry.pharmacology | en |
dc.subject.other | Phosphatidylinositol 3-Kinases.metabolism | en |
dc.subject.other | Protein Precursors.chemistry | en |
dc.subject.other | Signal Transduction.drug effects | en |
dc.title | The C-terminal flanking peptide (CTFP) of progastrin inhibits apoptosis via a PI3-kinase-dependent pathway. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Regulatory peptides | en |
dc.identifier.affiliation | Department of Surgery, University of Melbourne Austin Health, Heidelberg, Victoria, Australia 3084, Australia | en |
dc.identifier.doi | 10.1016/j.regpep.2010.08.005 | en |
dc.description.pages | 224-31 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/20727916 | en |
dc.type.austin | Journal Article | en |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.